Andere Sprachen BioVaxys Technology Corp.

Aktien

A2QE16

CA09076M1014

BIOV

Verzögert Canadian Securities Exchange Andere Börsenplätze 21:35:54 15.05.2024			% 5 Tage	% 1. Jan.
0.07 ^CAD	-12.50%		-.--%	+40.00%

02.05.	Biovaxys Technology Corp. verzögert die Einreichung des Zwischenabschlusses für die drei Monate bis zum 31. Januar 2024	CI
10.04.	Biovaxys und SpayVac-For-Wildlife, Inc. kündigen den Start eines Feldversuchs zur groß angelegten Immunokontrazeption in der kommerziellen Aquakultur an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioVaxys Technology Corp. Announces Failure to File Cease Trade Order	16.05.
CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)	16.05.
Canadian Investment Regulatory Organization Trading Halt - BIOV	16.05.
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement	10.05.
BioVaxys Technology Corp. Closes First Tranche of Private Placement	04.05.
Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024	02.05.
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	02.05.
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050	01.05.
BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer	30.04.
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	18.04.
Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry	10.04.
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY	10.04.
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	05.04.
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMage	03.04.
BioVaxys Technology Plans Private Placement; Down 5.9%	25.03.
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT	22.03.
BioVaxys Technology Corp. announced that it expects to receive CAD 1 million in funding	22.03.
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	21.03.
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	07.03.
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	07.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioVaxys Technology Corp.

Aktien

A2QE16

CA09076M1014

BIOV

Andere Sprachen

Filter